Забуті тропічні хвороби: проблеми та перспективи специфічної профілактики гельмінтних інвазій


  • A. S. Sydorchuk



Ключові слова:

тропічна медицина, вакцинація, «забуті тропічні хвороби», летальність


Огляд присвячений актуальній проблемі тропічної медицини - вивченню стану і перспектив розробки сучасних вакцин проти «забутих тропічних хвороб». Проведено аналіз світової наукової літератури з урахуванням сучасних даних про особливості розробки, складнощі на етапі клінічних випробувань. Висвітлено перспективні напрями створення нових вакцин для специфічної профілактики найпоширеніших тропічних гельмінтозів.


Hotez PJ, Beaumier CM, Gillespie PM. Advancing a vaccine to prevent hookworm disease and anemia. Vaccine. 2016;34:3001-05.

Kjetland EF, Ndhlovu PD, Gomo E. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS. 2006;20:593-600.

Bethony JM, Cole RN, Guo X. Vaccines to combat the neglected tropical diseases. Immunol. Rev. 2011;239:237-70.

Caldas IR. Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am. J. Trop. Med. Hyg. 2000;62:57-64.

Correa-Oliveira R, Caldas IR, Gazzinelli G. Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol. Today. 2000;16:397-99.

Hotez PJ, Bethony JM, Diemert DJ. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat. Rev. Microbiol. 2010;8:814-26.

Easterly W. An ivory tower analysis of real world povert. The Lancet. 2007;370:1475-76.

Moira de AP, Jones FM, Wilson S. Effects of Treatment on IgE Responses against Parasite Allergen-Like Proteins and Immunity to Reinfection in Childhood Schistosome and Hookworm Coinfections. Infect. Immun. 2013;81:23-32.

Mackey TK, Liang BA, Ryan RC. Emerging and Reemerging Neglected Tropical Diseases: a Review of Key Characteristics, Risk Factors, and the Policy and Innovation Environment. Clin. Microbiol. Rev. 2014;27:949-79.

Bruno E, Bartoloni A, Zammarchi L. Epilepsy and Neurocysticercosis in Latin America: A Systematic Review and Meta-analysis. PLoS Negl. Trop. Dis. 2013;7:2480.

Fitzpatrick C, Engels D. Leaving no one behind: a neglected tropical disease indicator and tracers for the Sustainable Development Goals. Int. Health. 2016;8:15-8.

Gause WC, Wynn TA, Allen JE. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat. Rev. Immunol. 2013;13:607-14.

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;385(9963):117-71.

Hewitson JP, Maizels RM. Vaccination against helminth parasite infections. Expert Rev. Vaccines. 2014;13:473-87.

Hotez PJ. How To Cure 1 Billion People? Defeat Neglected Tropical diseases. Scientific America. 2010;302(96):90-4.

Hotez PJ. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin. Pharmacol. Ther. 2009;85:659-64.

Jariwala AR. Potency testing for the experimental Na-GST-1 hookworm vaccine. Expert Rev. Vaccines. 2010;9:1219-230.

Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008;299:1937-48.

McCall LI, Zhang WW, Ranasinghe S, Matlashewski G. Leishmanization revisited: immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis. Vaccine. 2013;31:1420-25.

Fuaad AA, Pearson MS, Pickering DA. Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite. Chem. Med. Chem. 2015;10:1647-54.

Zhang W, Ahmad G, Le L. Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon. Parasitol. Res. 2014;113:2239-50.

Loukas A. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med. 2005;2:295.

Sripa B, Bethony JM, Sithithaworn P. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop. 2011;120:158-68.

Curti E, Seid CA, Hudspeth E. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate. Hum. Vaccin. Immunother. 2014;10:1914-25.

Roberts DJ. Hematologic Changes Associated with Specific Infections in the Tropics. Hematol. Oncol. Clin. North Am. 2016;30:395-415.

Santini-Oliveira M, Coler RN, Parra J. Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults. Vaccine. 2016;34:586-94.

Julé AM, Vaillant M, Lang TA. The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD). PLoS Negl. Trop. Dis. 2016;10:4784.

Bethony JM, Cole RN, Guo X. Vaccines to combat the neglected tropical diseases. Immunol. Rev. 2011;239:237-70.